PGF shares to debut on Catalyst

Pharmaceutical company Polska Grupa Farmaceutyczna will start trading bonds worth PLN 100 million on the Catalyst market on February 18, the company said. The decision to issue bonds was taken in November last year. Pelion Healthcare Group, the owner of PGF, has been present on the market for twenty-four years. Its services cover all market segments (wholesale, retail sale and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers.